Novel coronavirus continues to spread unabated The number of reported cases of COVID-19 continues to rise in all regions and in all age groups. The Municipal Public Health Service (GGD) reported that 43,903 people tested positive for COVID-19 in the past week.
Initial results of rapid antigen tests for COVID-19 very promising Two antigen tests for rapid diagnosis of COVID-19, which detect the presence of SARS-CoV-2 virus proteins within 15 minutes after testing, show very promising initial results.
Reports continue to rise The number of reports continues to rise in all regions and in all age groups. Last week, in the week of 30 September, 27,485 new people who tested positive for COVID-19 were reported by the Municipal Public Health Services (GGDs).
Standards for three drugs in Dutch surface water RIVM proposes water quality standards for three drugs in surface water: carbamazepine (epilepsy), metoprolol (heart disease) and metformin (diabetes).
Safety of the nanomaterial SAS (silica) in food still uncertain Uncertainty still remains over the safety of the nanomaterial SAS in food. Food additive E551 consists of ‘synthetic amorphous silica’ (SAS) and is applied as an anti-caking agent.
Open and sustainable building for RIVM and MEB The Central Government Real Estate Agency has awarded the contract to build new premises for two knowledge institutes - RIVM and the MEB - to StruktonHurks.
No new MERS patients in the Netherlands Almost two months ago, two Dutch people were diagnosed with the MERS coronavirus.
Declaration PAN Europe regarding RIVM Statement of PAN Europe regarding the contents of her report ‘A Poisonous Injection’ June 26, 2014.
Average participation in the National Immunisation Programme in the Netherlands around 95% From the RIVM report 'Vaccination level of the National Immunisation Programme of the Netherlands' (report year 2014) the strong commitment of Community Health Services (GGD’s) and child welfare ce
Examine patients with acute Q fever again after a year If patients with acute Q fever are re-examined for antibodies one year after their infection, 98% of the patients with chronic Q fever can be detected.